Hong Kong Institute of Integrative Medicine
Hong Kong
NCT Number: NCT05799391
This is a randomized, double-blinded, placebo-controlled clinical trial. This trial is used to evaluate the efficacy of soothing cream jel on chronic upper limb pain and the range of motion.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Interventional
Phase 2
Hong Kong
Potential subjects will be screened according to the eligibility criteria after signing the informed consent form. Subjects who fulfill the requirements will be randomized into either the treatment group or the placebo group. And receive either soothing cream jel or placebo cream jel for 2 weeks. Then followed by a post-treatment for 2 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Soothing cream jel
Other names: Soothing cream jel
Placebo cream jel
Time frame: From baseline to week 2
The range of motion of upper (shoulder or elbow) will be measured by a digital goniometer.
For the shoulder, active flexion and abduction ROMs are measured using a goniometer while the participants are standing. For the elbow, both flexion and extension will be measured by a goniometer in a standing position.
Time frame: From baseline to week 4
The range of motion of upper (shoulder or elbow) will be measured by a digital goniometer.
For the shoulder, active flexion and abduction ROMs are measured using a goniometer while the participants are standing. For the elbow, both flexion and extension will be measured by a goniometer in a standing position.
Time frame: 2 weeks
It contains 11 items in which subjects select a whole number (0-10 integers) that best reflects the average intensity of subjects' pain in the past week. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
Time frame: 4 weeks
It contains 11 items in which subjects select a whole number (0-10 integers) that best reflects the average intensity of subjects' pain in the past week. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
Time frame: 2 weeks
Handgrip strengths are measured by a dynamometer, on the dominant hand of the participant. Participants are instructed to hold the device with the arm at the right angle and elbow to the side of the body. The maximum effort will be taken from three attempts.
Time frame: 4 weeks
Handgrip strengths are measured by a dynamometer, on the dominant hand of the participant. Participants are instructed to hold the device with the arm at the right angle and elbow to the side of the body. The maximum effort will be taken from three attempts.
Time frame: 2 weeks
The back-scratch test is used to measure the overall shoulder ROM. It is performed by measuring the distance between (or the overlap of) the middle fingers of both hands behind the back with a ruler.
Time frame: 4 weeks
The back-scratch test is used to measure the overall shoulder ROM. It is performed by measuring the distance between (or the overlap of) the middle fingers of both hands behind the back with a ruler.
Time frame: 2 weeks
The ASESp-S consists of 18 questions from 3 sections: pain, instability and activities of daily living (ADL). Among the 18 questions, 11 self-report items represented functional ADL dimension (10 items) and pain dimension (1 item). The ADL section was scored on a 4-points-graded ordinal scale, ranging from 0 (unable to do) to 3 (not difficult) and cumulative scores were collected. The pain section was derived from the 10-points-graded visual analog scale (VAS) ranging from 0 (no pain) to 10 (maximum pain).
Time frame: 4 weeks
The ASESp-S consists of 18 questions from 3 sections: pain, instability and activities of daily living (ADL). Among the 18 questions, 11 self-report items represented functional ADL dimension (10 items) and pain dimension (1 item). The ADL section was scored on a 4-points-graded ordinal scale, ranging from 0 (unable to do) to 3 (not difficult) and cumulative scores were collected. The pain section was derived from the 10-points-graded visual analog scale (VAS) ranging from 0 (no pain) to 10 (maximum pain).
Time frame: 2 weeks
The ASESp-E consists of 3 sections: pain, function, and satisfaction. Patients are asked about the spot of pain in their elbow and asked to rate pain on a visual analog scale (VAS) in different situations, such as the worst of pain, at rest, lifting a heavy object, doing a task with repeated elbow movements and at night. The VAS ranges from 0 (no pain) to 10 (maximum pain). In the function section, patients are asked to rate their ability to perform 10 ADL and their usual work and sporting activities with the scale from 0 (unable to do) to 3 (not difficult).
Time frame: 4 weeks
The ASESp-E consists of 3 sections: pain, function, and satisfaction. Patients are asked about the spot of pain in their elbow and asked to rate pain on a visual analog scale (VAS) in different situations, such as the worst of pain, at rest, lifting a heavy object, doing a task with repeated elbow movements and at night. The VAS ranges from 0 (no pain) to 10 (maximum pain). In the function section, patients are asked to rate their ability to perform 10 ADL and their usual work and sporting activities with the scale from 0 (unable to do) to 3 (not difficult).
Time frame: 2 weeks
SF36 is a generic instrument to measure general health status. It will be used to assess the patient's health status using 8 different dimensions including vitality, physical functioning, bodily pain, general health perceptions, role limitations due to physical health, role limitations due to emotional health, social role functioning and mental health. The possible score ranges from 0 to 100 points whereby 0 points represent the greatest possible limitation of health, while 100 points represent the absence of health restrictions.
Time frame: 4 weeks
SF36 is a generic instrument to measure general health status. It will be used to assess the patient's health status using 8 different dimensions including vitality, physical functioning, bodily pain, general health perceptions, role limitations due to physical health, role limitations due to emotional health, social role functioning and mental health. The possible score ranges from 0 to 100 points whereby 0 points represent the greatest possible limitation of health, while 100 points represent the absence of health restrictions.
Time frame: From baseline to week 4
If participants used any other drugs or treatments for the pain symptom during the whole study period, those drug names or treatments would be recorded.
Chinese University of Hong Kong
Other
Efficacy of Soothing Cream Jel in Improving the Range of Motion and Chronic Pain at Shoulder and Elbow: A Double-blinded, Randomized, Placebo-Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06366633
Chemically-Induced Disorders, Chronic Pain
Boston, Massachusetts, United States
View Trial DetailsNCT06278740
Central Nervous System Diseases, Muscular Diseases
Afyonkarahisar, Turkey (Türkiye)
View Trial DetailsNCT05980078
Upper Extremity Problem
Austin, Texas, United States
View Trial DetailsNCT06373315
Behavior, Behavior, Addictive
Niğde, Niğde Province, Turkey (Türkiye)
View Trial Details